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ABSTRACT
The carbon catabolite repressor protein 4 (Ccr4)–
Negative on TATA (Not) complex controls gene
expression at two levels. In the nucleus, it regulates
the basal transcription machinery, nuclear receptor-
mediated transcription and histone modifications. In
the cytoplasm, the complex is required for messenger
RNA (mRNA) turnover through its two associated
deadenylases, Ccr4 and Caf1. Not1 is the largest
protein of the Ccr4–Not complex and serves as a
scaffold for other subunits of the complex. Here, we
provide evidence that human Not1 in the cytoplasm
associates with the C-terminal domain of tristetra-
prolin (TTP), an RNA binding protein that mediates
rapid degradation of mRNAs containing AU-rich
elements (AREs). Not1 shows extensive interaction
through its central region with TTP, whereas binding
of Caf1 is restricted to a smaller central domain within
Not1. Importantly, Not1 is required for the rapid decay
of ARE-mRNAs, and TTP can recruit the Caf1 dead-
enylase only in presence of Not1. Thus, cytoplasmic
Not1 provides a platform that allows a specific RNA
binding protein to recruit the Caf1 deadenylase and
thereby trigger decay of its target mRNAs.
INTRODUCTION
Cells maintain tight control of gene expression by
regulating rates of transcription, messenger RNA
(mRNA) stability, protein translation and protein stabil-
ity. Genes that are rapidly turned on and off frequently
achieve such dynamic expression patterns by synthesizing
short-lived mRNAs. Genome-wide studies in stimulated T
cells, macrophages and ﬁbroblasts revealed that mRNA
half-life is a major determinant of gene expression
patterns (1,2). An adenosine/uridine-rich element (ARE)
is located in the 30-untranslated region (UTR) of many
short-lived mRNAs and mediates rapid mRNA degrad-
ation (3,4). Examples of mRNAs containing potent
AREs include many cytokine transcripts such as tumor
necrosis factor-a (TNF-a), granulocyte-macrophage
colony-stimulating-factor (GM-CSF) and interleukin
(IL)-3mRNAaswellasmRNAsencodingfortranscription
factors such as c-myc, c-fos and Ier3 (5).
Tristetraprolin (TTP) is an RNA binding zinc-ﬁnger
protein required for ARE-mediated mRNA decay
(AMD). The physiological role of TTP as an inhibitor
of TNF-a expression was discovered by the analysis of
TTP knock out mice (6). TTP was found to act at the
post-transcriptional level by binding to the ARE of
TNF-a mRNA and accelerating its degradation (7). TTP
recognizes the ARE via its two cysteine–cysteine–cysteine–
histidine (CCCH) zinc-ﬁnger domains. In addition to
TNF-a, TTP was shown to mediate rapid degradation
of the mRNAs encoding GM-CSF (8), IL-2 (9), IL-3
(10), IL-10 (11) and Ier3 (12). The TTP family of
proteins comprises two additional paralogs, BRF1 and
BRF2, which also promote AMD (13,14).
AREs destabilize mRNA by inducing a rapid short-
ening of the poly(A) tail (15). Subsequent degradation
of the mRNA body occurs either from the 30-end
through the exosome (16–18) or from the 50-end through
decapping followed by Xrn1-mediated mRNA decay
(19–21). Importantly, deadenylation is the ﬁrst and
rate-limiting step for both decay pathways. Several
poly(A)-speciﬁc exoribonucleases in the cytoplasm share
the job of shortening poly(A) tails. Whereas the Pan2–
Pan3 complex was found to hydrolyse poly(A) in a dis-
tributive manner, the carbon catabolite repressor protein 4
(Ccr4)–Negative on TATA (Not) complex hydrolyses
poly(A) in a processive manner and is responsible for
rapid deadenylation (22). According to an early yet still
valid classiﬁcation, the highly potent class II AREs of
cytokine mRNAs cause asynchronous deadenylation
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whereas class I AREs, found e.g. in the 30-UTR of the
c-fos and c-myc transcription factors, cause synchronous
deadenylation as the result of a distributive deadenylase
activity. TTP typically interacts with class II AREs of
TNFa, GM-CSF and IL-3 mRNA (7,8,23), and may
thus recruit a processive deadenylase. In vitro decay
studies suggested involvement of the poly-A ribonuclease
(PARN) since recombinant TTP was found to stimulate
PARN-induced deadenylation of an ARE-mRNA (24).
Given that a direct interaction of TTP with PARN
could not be observed, it is not clear how TTP activates
or recruits PARN. In a different study, TTP was found
to interact through its N-terminal domain with the Ccr4
deadenylase (20), and more recently, TTP was shown
to interact with Caf1 (25). Functional studies on the
relative importance of Ccr4 and Caf1 deadenylases
are challenging since multiple paralogs exist for both
proteins in the human genome. Studies with dominant-
negative mutants of Ccr4 and Caf1 suggested that
Ccr4 may have a predominant role in the regular
turnover of mRNAs lacking a dedicated destabilizing
element (22,26). By knocking down simultaneously
Ccr4a (CNOT6) and Ccr4b (CNOT6L) or Caf1a
(CNOT7) and Caf1b (CNOT8, also CALIF or POP2)
in human HT1080 cells, we could previously show that
Caf1a/b are required for the degradation of a reporter
mRNA containing the ARE of GM-CSF (a typical
class II ARE), whereas the knock down of Ccr4a/b had
no effect (27). In human, Ccr4 and Caf1 together are
part of the large, 1.2 MDa Ccr4–Not complex that
comprises Not1 (CNOT1), Not2 (CNOT2), Not3
(CNOT3), Caf40 (CNOT9 or Rcd1), CNOT10, TAB182
and C2ORF29 (28,29). In the nucleus, the Not1, Not2
and Caf40 subunits of the human Ccr4–Not complex
play a role as regulators of transcription (30,31). Not1,
e.g. binds to oestrogen receptor and thereby represses
ligand-dependent transcriptional activation (31). In
addition, studies in Saccharomyces cerevisiae showed
that the Not subunits and Not4, in particular, are
required to maintain normal levels of histone methylation
(32,33). As for the cytoplasmic function of the Ccr4–Not
complex, early studies in yeast identiﬁed Ccr4 and Caf1
(also termed Pop2) as major cytoplasmic deadenylases
(34,35). In yeast, Ccr4 appears to be more active than
Caf1 (36,37), whereas Caf1 seems to be the major
deadenylase in Drosophila, trypanosomes and mammalian
cells (27,38,39). Yeast studies further found that Not2
and Not5 enhance the deadenylation rate of cytoplasmic
mRNAs and may thus serve as activators of Ccr4 or
Caf1 (36). A detailed analysis in Drosophila showed
that in addition to Caf1, Not1, Not2 and Not3 are
critical for rapid deadenylation of both bulk and Hsp70
mRNA (38).
In this study, we puriﬁed proteins associated with TTP
and found that TTP interacts with Not1. We show that
Not1 is required for TTP-mediated mRNA decay, map
the regions involved in the TTP–Not1 interaction and
provide evidence that TTP recruits the Caf1 deadenylase
via its interaction with Not1.
MATERIALS AND METHODS
Plasmid construction
Plasmids pcDNA3-TTP-mycHis (p2115), pTet-7B (p2254)
and pTet-7B-ARE (p2260) have been described previously
(40). For pTet-7B-MS2bs (p2255), six repeats of the
improved MS2-binding site were ampliﬁed by PCR with
primers G37 and G38 (Supplementary Table S1) from
plasmid b-6bs (41) and ligated as a BamHI—BglII
fragment into the BglII site of pTet-7B.
The Tet-inducible TOPuro (p2433) vector was created
by cloning a PvuII—BamHI fragment from pPUR
(Clontech) containing a puromycine resistence gene into
the PvuII/BamHI sites of pcDNA4/TO (Invitrogen). For
plasmid TOPuroGS (p2434) containing a protein-G and
streptavidin-binding peptide tag for N-terminal fusions,
the GS tag was ampliﬁed by PCR from plasmid pCeMM-
NTAP(GS)-Gw (42) using primers G1050/G1051 and
inserted into the KpnI/BamHI sites of TOPuro. For
TOPuroGS-TTP-wt (p2436), the mouse TTP cDNA was
ampliﬁed by PCR using primers G1052/G1053 from
pcDNA3-TTPwt-mycHis (p2115) and ligated into the
EcoRI/XhoI sites of TOPuroGS (p2434). To generate
TOPuro-mycSG (p2484) for C-terminal fusions of a
mycSG- tag, mycSG was ampliﬁed by PCR from
pCeMM-CTAP(SG)-Gw (p2432) (42) using primers
G1120/G1121 that contain a SalI and XhoI linker, respect-
ively, and cloned into the XhoI site of TOPuro (p2433).
Based on TOPuro-mycSG, TOPuro-Caf1a-mycSG
(p2485) encoding human wt Caf1a and TOPuro-Caf1a-
AA-mycSG (p2737) containing the D40A/E42A mutation
were cloned as described previously (43).
For pcDNA3-YFP-TTP (p2789), pcDNA3-YFP-TTP-
M1,2 (p2712), pcDNA3-YFP-TTP-N (p2790), pcDNA3-
YFP-TTP-NZ (p2791) and pcDNA3-YFP-TTP-C
(p2792), the TTP cDNA fragments were taken out of
the corresponding pcDNA3-TTP-mycHis plasmids (40)
and cloned into the EcoRI/XbaI sites of pcDNA3-YFP
(p2168) described previously (43). The TTP-M1,2 mutant
was kindly provided by Keith Blackwell (Joslin Diabetes
Center, Boston, USA).
For pcDNA3-MS2cp-TTP-mycHis (p2200), the MS2cp
was excised from pcNMS2 (41) using HindIII and ligated
into the HindIII site of pcDNA3-mTTP-mycHis (p2115).
pcDNA3-MS2cp-TTP-M1,2-mycHis (p2203) was
generated in the same way using pcDNA3-TTP-M1,2-
mycHis (p2117) as the vector. To clone pcDNA3-MS2cp-
mycHis (p2205), pcDNA3-MS2cp-TTP-mycHis was
opened with KpnI/XbaI to release TTP, and the vector
was blunt-end religated. For pcDNA3-MS2cp-TTP-
C-mycHis (p2808) and pcDNA3-MS2cp-TTP-N-mycHis
(p2806), TTP was replaced in the pcDNA3-MS2cp-TTP-
mycHis vector with the C- or N-terminus of TTP, respect-
ively, by swapping with a ClaI—XbaI fragment from
pcDNA3-TTP-C-mycHis (p2122) or pcDNA3-TTP-N-
mycHis (p2123) (40).
pCMV-Flag-Not1 (p2556) encoding full-length Not1
has been described previously (31). For pCMV-
Flag-Not1:1-700 (p2594), pCMV-Flag-Not1 was digested
with NheI/XbaI and religated, thereby ejecting the region
encoding amino acid 701–2376 of Not1. To generate
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with XbaI and religated, thereby ejecting the region
encoding aa 998–2376 of Not1. The empty vector
pcDNA3-Flag (p2002) contains the sequence ACC ATG
GAC TAC AAG GAC GAT GAC GAC AAG between
the HindIII and BamHI sites of pcDNA3 (Invitrogen).
For pcDNA3-HA-Not1:727-1449 (p2642), pCMV-
Flag-Not1 was digested with PvuII, and the 2172-bp
fragment was ligated into the EcoRV site of pcDNA3-
HA (p2003) described previously (43). Subsequently the
HA tag was replaced by the YFP tag from plasmid
pcDNA3-YFP by a HindIII/KpnI digest. From the same
PvuII digest of pCMV-Flag-Not1, the 1911-bp fragment
was cloned into the EcoRV site of pcDNA3-HA
to generate pcDNA3-HA-Not1:1880-2376 (p2657). For
pcDNA3-YFP-Not1:1880-2376 (p2693), the HA tag
was then replaced by YFP via an SpeI/BamHI digest.
For pcDNA3-HA-Not1:1330-1601 (p2673), the Not1
fragment 1330–1601 was ampliﬁed by PCR using primers
G1653/G1654 and cloned into the BamHI/XhoI sites
of pcDNA3-HA. Subsequently the HA tag was replaced
by YFP via an SpeI/BamHI digest to generate pcDNA3-
YFP-Not1:1330-1601 (p2694). For HA-tagged Ccr4a,
the CNOT6 cDNA was cloned into the pMT2MS-HA
vector.
Cell culture and transfection
HeLa and HEK293T cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM; Gibco) supplemented
with 10% fetal calf serum (FCS) (Gibco), 2mM L-glutam-
ine, 100 U/ml penicillin and 0.1mg/ml streptomycin
(all PAN). T-REx-HeLa- cells (Invitrogen) were cultured
in the same medium containing 10% tetracycline-negative
FCS (PAA). All cells were grown at 37 C and 5% CO2.
Cells were transfected with DNA using polyethyl-
eneimine (PEI) (Polysciences Europe; 1mg/ml, pH 7.0)
at a ratio of 1:2 (DNA:PEI) in serum-free DMEM
without antibiotics. For transfection of siRNAs,
Lipofectamine 2000 (Invitrogen) and Optimem (Gibco)
were used according to the manufacturer’s protocol.
Medium was changed to regular DMEM 4h after
transfection of DNA or siRNA.
TTP puriﬁcation
T-REx-HeLa cells stably transfected with TOPuroGS
or TOPuroGS-TTP-wt were treated with doxycycline
(1mg/ml) for 16h to induce expression of the proteins.
Cytoplasmic lysates were prepared from  2 10
8 cells
using RNP lysis buffer (1% NP40, 150mM NaCl,
50mM Tris–HCl, pH 8.0, 1mM MgCl2, 10% glycerol,
1mM dithiothreitol, 1mM Na2VO3, 50mM NaF and
40nM okadaic acid), and tagged proteins were bound to
streptavidin sepharose (GE Healthcare). The beads were
washed ﬁve times with RNP buffer and eluted by the
addition of biotin (1mM, pH 5.0). The eluate was
concentrated by vacuum centrifugation, resolved on a
5–20% gradient polyacrylamide gel, and proteins were
visualized by colloidal Coomassie staining.
In-gel tryptic digestion and LC-MS/MS analysis
Mass spec analyses were carried out at the core facility for
mass spectrometry and proteomics of the Center for
Molecular Biology at the University of Heidelberg
(ZMBH). Proteins in the gel were stained with colloidal
Coomassie, and the entire lane was cut into ﬁve gel slices
with a scalpel. Gel slices were transferred to a 96-well plate
and reduced, alkylated and digested with trypsin (44)
using a Digest pro MS liquid handling system (Intavis).
Following digestion, tryptic peptides were extracted from
the gel pieces with 50% acetonitrile/0.1% triﬂuoroacetic
acid (TFA), concentrated nearly to dryness in a vacuum
centrifuge and diluted to a total volume of 30ml with 0.1%
TFA; 25ml of the sample was analyzed by a nano-HPLC
system (Eksigent 1D plus) coupled to a ESI LTQ Orbitrap
mass spectrometer (Thermo Fisher). Sample was loaded
on a C18 trapping column (Inertsil, LC Packings) with a
ﬂow rate of 10ml/min 0.1% TFA. Peptides were eluted
and separated on an analytical column (75mm 150mm)
packed with Inertsil 3mm C18 material (LC Packings)
with a ﬂow rate of 200 nl/min in a gradient of buffer A
(0.1% formic acid) and buffer B (0.1% formic acid, aceto-
nitrile): 0–6min: 3% B; 6–60min: 3–40% B; 60–65min:
60–90% B. The column was connected with a nano-ESI
emitter (New Objectives), and 1500 V was applied via
liquid junction. One survey scan (resolution: 60000) was
followed by ﬁve information-dependent product ion scans
in the LTQ. Only doubly and triply charged ions were
selected for fragmentation. All MS/MS samples were
analyzed using Mascot (Matrix Science; version 2.2.03).
The NCBInr database (taxonomy: homo sapiens,
204932 entries) was used with the following search par-
ameters: cleavage with trypsin, parent ion tolerance of
4.0ppm and fragment ion mass tolerance of 0.20 Da.
Iodoacetamide derivative of cysteine was speciﬁed in
Mascot as a ﬁxed modiﬁcation. Deamidation of aspara-
gine and oxidation of methionine were speciﬁed as
variable modiﬁcations.
Immunoprecipitation and western blot analysis
Cells were transiently transfected 24–48h prior to lysis.
When Tet-inducible expression vectors were used, cells
were treated over night with 1mg/ml doxycycline
(Sigma). Typically, cells from a 10-cm dish were
solubilized in 400ml RNP lysis buffer and nuclei were
removed by centrifugation. YFP-tagged proteins were
puriﬁed using the GFP-binder as described in Ref. (45).
Cytoplasmic lysates were allowed to bind afﬁnity matrices
for 2–4h at 4 C prior to washing. For IPs with speciﬁc
antibodies, cytoplasmic lysates were pre-cleared by the
addition of 30ml protein A/G agarose beads (Thermo
Scientiﬁc) for 1h at 4 C, incubated with 1mgo f
antibody for 2h and 30ml of protein A/G beads for add-
itional 2h before washing. Three to ﬁve washes were
carried out using RNP lysis buffer. From the GFP-
binder and the protein A/G agarose beads, proteins were
eluted with 1% SDS-containing sample buffer. Where
indicated, RNase A (Genomed) was added during the IP
at a concentration of 1mg/ml. RNase I (Ambion) was used
at a concentration of 500 U/ml. RNA was extracted from
Nucleic Acids Research, 2011,Vol.39, No. 10 4375the unbound fraction using TriFast (Peqlab) according to
manufacturer’s protocol.
Proteins were resolved on 5–20% gradient polyacryl-
amide gels and transferred onto 0.2mm pore size nitrocel-
lulose membranes (Peqlab) for western blotting.
Horseradish peroxidase-coupled secondary antibodies
(Jackson Immunoresearch) in combination with Western
Lightning-enhanced chemiluminescence substrate (Perkin
Elmer) were used for detection on chemiluminescence ﬁlm
from GE Healthcare.
Antibodies
The following antibodies were used for IP and western
blot analysis: Mouse monoclonal anti-HA (HA.11,
Covance), anti-myc 9E10 (MMS-150P, Covance),
anti-Flag (M2, Sigma Aldrich), rabbit polyclonal
anti-GFP (Abcam ab290) and anti-14-3-3 K-19 (Sant
Cruz, sc-629). Anti-Caf1a antibody was kindly provided
by Ann-Bin Shyu (University of Texas, Houston, TX,
USA).
Northern blot analysis
For RNA decay experiments, HeLa cells were transiently
transfected with pTet-Off (Clontech) and a pTet-7B
reporter plasmid; 1mg/ml doxycycline (Sigma) was added
to cell cultures for indicated time periods and total RNA
was extracted using the Genematrix RNA puriﬁcation kit
(Eurx, Roboklon). To generate deadenylated mRNA, the
20mg of total RNA was annealed with 1nmol/ml oligo
dT18 in presence of 1mM EDTA for 15min at 26 C.
RNA:DNA hybrids were digested using 5 U/ml RNase
H (NEB) for additional 15min at 37 C. RNA was ex-
tracted with phenol:chloroform:isoamylalcohol (50:50:1)
and precipitated; 5–15mg of RNA was resolved by 1.1%
agarose/2% formaldehyde/MOPS gel electrophoresis and
blotted over night with 8 saline-sodium citrate (SSC)
buffer onto Hybond-N+ Nylon membranes (GE
Healthcare). Membranes were hybridized overnight at
55 C with digoxigenin-labeled RNA probes synthesized
in vitro using Sp6 polymerase (Fermentas). Membranes
were washed twice with 2  SSC/0.1% SDS for 5min,
and twice with 0.5  SSC/0.1% SDS for 20min at 65 C.
Alkaline phosphatase-coupled anti-digoxigenin Fab frag-
ments and CDP-Star substrate (both Roche) were used for
detection according to the manufacturer’s instructions.
The following primers were used to generate templates
for Sp6 probes by PCR: G1000 and G1001 for the
probe against exons 1 and 2 of rabbit b-globin; G83 and
G1009 for the probe against human nucleolin.
Real-time PCR
cDNA was synthesized from 5mg of total RNA using
oligo-dT18 (Invitrogen) and M-MLV H(–) reverse tran-
scriptase (Promega). PCRs were carried out with 1:40 of
a cDNA reaction, 200nM target-speciﬁc primers and
SYBR Green Mastermix (Roche) in a total volume of
10ml on a Lightcycler 480 (Roche). The following
primers were used: G1578/G1579 for Not1, and G1576/
G1577 for nucleolin as internal control.
siRNAs
Cells were transfected twice with siRNA at a ﬁnal concen-
tration of 100nM over a period of 4 days using
Lipofectamine 2000 (Invitrogen). The siRNA concen-
tration was 50 nm each in cases where two siRNAs were
transfected simultaneously. Where indicated, plasmid
DNA was added to the second siRNA transfection.
siRNAs were synthesized by Ambion and correspond to
the following sequences (sense strand):
D0/S015 (control), 50-GCAUUCACUUGGAUAGUA
AdTdT-30; C2/S014 (control), 50-GCAUUCACUUGGA
UAGUAAdTdT-30; U0 (control), 50-GAAUGCUCAUG
UUGAAUCAdTdT-30 S021 (Not1), 50-GGAACUUGU
UUGAAGAAUAdTdT-30; S034 (Not1), 50-GAGGAUG
ACAAUCGAGAAAdTdT-30.
RESULTS
Not1 interacts with TTP
In order to identify proteins that associate with TTP, we
generated a Tet-inducible vector expressing GS-tagged
TTP. This tag encodes for protein G and a streptavidin-
binding peptide (42). Stably transfected HeLa T-REx cells
were generated with inducible expression of GS-TTP, and
the fusion protein was afﬁnity-puriﬁed on streptavidin
sepharose. Due to difﬁculties with TEV cleavage, we
could not perform a two-step puriﬁcation as intended ini-
tially. Upon elution with biotin, co-purifying proteins
were visualized by Coomassie staining and compared to
proteins co-purifying with the GS tag alone (Figure 1A).
Proteins from both puriﬁcations were identiﬁed by mass
spectrometry. If a protein was identiﬁed by three or more
peptides, and if the peptide number was  3-fold higher
in the GS-TTP puriﬁcation compared with the GS puriﬁ-
cation, it was considered a potential candidate associated
with TTP (Supplemental Table S2). Among previ-
ously known interacting partners (46), we found 14-3-3
adaptor proteins (40,47) to co-purify with wild-type TTP
(Figure 1A), but not with a non-phosphorylatable S52A/
S178A mutant of TTP (data not shown). Interestingly, ﬁve
of the seven isoforms of 14-3-3 could be identiﬁed in our
mass spec analysis, suggesting that the interaction of
phospho-TTP with 14-3-3 is not isoform-speciﬁc.
We further noticed that a large protein >200kDa in size
co-puriﬁed with GS-TTP (Figure 1A), and this protein
was identiﬁed as Not1 (Supplementary Table S2). Not1
is the scaffold protein of the Ccr4–Not complex that regu-
lates transcription in the nucleus and contains two major
cytoplasmic deadenylases, Ccr4 and Caf1 (48). Since Ccr4
and Caf1 are required for turnover of eukaryotic mRNAs
(27,34,35,39,49), we further explored the interaction of
Not1 with TTP. By transient transfection in HEK293
cells, we found that yellow ﬂuorescent protein (YFP)-
tagged TTP co-IPs with Flag-tagged Not1, whereas YFP
alone did not (Figure 1B, lanes 3 and 4). By inverse IP we
conﬁrmed that Flag-Not1 co-IPs with myc-tagged TTP,
whereas the Flag tag alone does not (Figure 1C, lanes 3
and 4). We then expressed the TTP mutant M1,2 (50),
which does not bind RNA because of CCCH to SSCH
4376 Nucleic Acids Research, 2011,Vol.39, No. 10mutations in both of its zinc ﬁngers. IP analysis showed
that Flag-Not1 was efﬁciently co-immunoprecipitated
with both wt and mutant TTP (Figure 1D, lanes 6 and
8). Likewise, addition of RNase A during the IP did not
abolish the interaction between YFP-TTP and Flag-Not1
(Figure 1D, lanes 7 and 9), suggesting that the interaction
between TTP and Not1 is RNA-independent. Lack of
RNA binding by TTP-M1,2 was conﬁrmed by RNA-IP:
whereas wt TTP efﬁciently co-puriﬁed with a globin-ARE
reporter mRNA (Figure 1E, lane 5) and the zinc-ﬁnger
mutant TTP-M1,2 did not (lane 6).
Not1 is required for TTP-mediated mRNA deadenylation
and decay
Next, we determined whether Not1 is required for AMD.
We ﬁrst reduced Not1 expression by transfection of two
different siRNAs in HeLa cells, and subsequently trans-
fected TTP together with a b-globin reporter gene that
contains the ARE of TNFa in its 30-UTR and is driven
by a tetracycline-sensitive promoter. Degradation of the
reporter mRNA was measured after blocking its
transcription with doxycycline. In the presence of two dif-
ferent control siRNAs, the globin-ARE mRNA showed
very rapid deadenylation and subsequent degradation
(Figure 2A, left panels). In contrast, both siRNAs
directed against Not1 caused a strong stabilization of
the globin-ARE mRNA (right panels). By analyzing the
reporter mRNA size, we noticed that the globin-ARE
mRNA remained above the 800nt mark after Not1
knock down, whereas it was shortened to  700nt in the
control conditions. A lower exposure of the globin-ARE
mRNA signal in the second panel of Figure 2A clearly
shows the deadenylated mRNA species that is present in
the control knock downs, but absent in the Not1 knock
downs. The difference was visualized by plotting the signal
intensity as a function of mRNA size in the panels below
of the northern blots of Figure 2A. This result indicated
that Not1 is primarily required for full deadenylation of
the reporter mRNA. Quantiﬁcation of the overall mRNA
signals in three biological repeat experiments showed that
knocking down Not1 increases the half-life of globin-ARE
mRNA from 0.5 to 1.2h (Figure 2B). By quantitative
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Figure 1. TTP interacts with Not1 independently of RNA. (A) T-REx-Hela cells were stably transfected with either the GS tag alone or GS-TTP,
and treated with doxycycline for 16h to induce expression of the tagged proteins. Cytoplasmic lysates were prepared from  2 10
8 cells, and tagged
proteins were puriﬁed using streptavidin sepharose. Proteins were eluted with biotin, resolved on a 5–20% gradient polyacrylamide gel and visualized
by colloidal Coomassie staining. (B) HEK293 cells were transiently transfected with Flag-Not1 together with either YFP or YFP–TTP. After 1day,
cytoplasmic lysates (input) were prepared for IP with GFP-binder. Western blot analysis was carried out with antibodies against the Flag and YFP
tags. (C) HEK293 cells were transiently transfected with TTP-myc together with either Flag alone or Flag-Not1. Cytoplasmic lysates were used for IP
with Flag antibody, and western blots analysis was carried out with antibodies against the myc and Flag tags. (D) HEK293 cells were transiently
transfected with Flag-Not1 together with YFP, YFP–TTP or the zinc-ﬁnger mutant YFP–TTP-M1,2. IP and western blot analysis was carried out as
in panel B, except that RNase A was added during IP where indicated. (E) HeLa cells were transiently transfected with a b-globin reporter gene
containing the ARE of TNFa in its 30-UTR. In addition, cells were transfected with YFP, YFP–TTP or the zinc-ﬁnger mutant YFP–TTP–M1,2.
RNA and protein were extracted from both the input and IP samples. Western blot analysis was carried out with an antibody against YFP, and
globin-ARE as well as nucleolin mRNA were detected by northern blot analysis.
Nucleic Acids Research, 2011,Vol.39, No. 10 4377PCR, we determined that the two siRNAs reduced Not1
mRNA expression levels to  10% and 30%, respectively
(Figure 2C). Knock down efﬁciency was also conﬁrmed at
the protein level, as both siRNAs reduced Flag-Not1
levels below the detection limit of our western blot
analysis (Figure 2D). Taken together, we concluded
from these experiments that Not1 is required for AMD
of a reporter mRNA containing a class II ARE.
Since several ARE-binding proteins including TTP,
BRF1, KSRP and AUF1 participate in AMD (51), we
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Figure 2. Not1 is required for ARE-mediated mRNA deadenylation and decay. (A) HeLa cells were transfected with two independent control
siRNAs or two siRNAs targeting Not1. After 48h, cells were transfected again with the same siRNAs together with a plasmid encoding TTP, a
pTet-Off-driven b-globin reporter gene containing the ARE of TNF-a in its 30 UTR, and the Tet-Off transactivator. Reporter gene transcription was
blocked speciﬁcally by addition of doxycycline 24h after the second transfection, and RNA was isolated after the time intervals indicated.
Globin-ARE and nucleolin mRNA were detected by northern blot analysis; a high and low exposure is provided for the globin-ARE signal. The
size of the mRNA was determined by comparison to an RNA marker. In the bottom panel, deadenylation was visualized by quantifying the signal
intensity of globin-ARE mRNA along the length of the signal and plotting it as a function of mRNA size. (B) Quantiﬁcation of the globin-ARE
reporter mRNA decay in panel A and repeat experiments. Signal intensities of globin-ARE mRNA were normalized to nucleolin mRNA and
represented as % of the initial value. Results from the two control and the two Not1 siRNA transfections were combined. The graph shows average
values±SE from eight (si-control) and six (si-Not1) biological repeat experiments. (C) HeLa cells were transfected twice with siRNAs as in panel A.
Not1 mRNA levels were quantiﬁed by real-time PCR using nucleolin mRNA for normalization. (D) HEK293 cells were ﬁrst transfected with
Flag-Not1, and 1day later with the siRNAs indicated. After one additional day, cytoplasmic lysates were prepared and analyzed by western blotting
using antibodies against Flag and 14-3-3.
4378 Nucleic Acids Research, 2011,Vol.39, No. 10then tested whether an mRNA whose decay is mediated by
TTP alone would also require Not1 for degradation. For
this purpose, we chose a tethering approach whereby TTP
is forced to bind an mRNA lacking an ARE through the
tight interaction of the MS2 bacteriophage coat protein
(cp) with its cognate binding site (bs) in the MS2 RNA.
MS2cp-TTP fusion proteins were expressed in HeLa cells
together with a b-globin reporter mRNA containing six
repeats of the MS2bs in its 30-UTR. Figure 3A shows that
tethering of MS2cp-TTP causes rapid degradation of the
mRNA, whereas the mRNA remains stable after tethering
of MS2cp alone. Tethering of the TTP-M1,2 mutant,
which does not bind RNA, was as efﬁcient as tethering
of wt TTP (Figure 3A). This conﬁrms that TTP functions
by recruiting components of the RNA decay machinery to
the bound RNA (16,20). We then tested the effect of
knocking down Not1 by transfecting two siRNAs (S021
and S034) simultaneously. As seen with the
ARE-containing mRNA above, we observed that the
mRNA tethered to MS2cp-TTP-M1,2 was stabilized by
knock down of Not1 (Figure 3B). Quantiﬁcation of four
biological repeat experiments showed an increase in the
mRNA half-life from 1.6h to >6h. Thus, mRNA decay
mediated by binding of TTP alone is clearly dependent on
the deadenylase scaffold protein Not1.
Caf1 is required for TTP-induced mRNA deadenylation
In yeast, Ccr4 and Caf1 were found to be the major cyto-
plasmic deadenylases (35), whereas in trypanosomes,
Drosophila and human cells, Caf1 appears to be the
predominant deadenylase (27,49). Previously, we have
shown that in human HT1080 ﬁbrosarcoma cells, Caf1
is of particular importance for the rapid degradation of
an ARE-containing mRNA (27). To further establish the
link between Caf1 and AMD, we examined whether TTP
could co-IP with endogenous Caf1a in HEK293 cells.
Indeed, we found that YFP-tagged TTP associates with
Caf1a (Figure 4A, lane 6), whereas YFP alone did not
(lane 4). Importantly, addition of RNase A to the IP did
not reduce the interaction of YFP-TTP with Caf1a (lane
7). Given that YFP-TTP-M1,2 also co-IPs with Caf1a
(lanes 8 and 9), we concluded that TTP associates with
the Caf1 deadenylase in an RNA-independent manner.
We then tested whether Caf1 is important for
TTP-induced mRNA degradation. Since knocking down
both Caf1a and Caf1b together is not very efﬁcient (27),
we made use of a dominant-negative mutant of Caf1a,
Caf1a-AA (D40A/E42A), which can efﬁciently prevent
deadenylation (43). TTP was expressed together with
a globin-ARE reporter mRNA in order to accelerate
AMD (Figure 4B). Compared with vector control,
co-expression of Caf1a-wt had only a small effect on the
deadenylation pattern and decay rate of globin-ARE
mRNA. Conversely, co-expression of dominant-negative
Caf1a-AA strongly reduced both deadenylation and decay
of the ARE-containing reporter mRNA. Figure 4B shows
that only about half of the poly(A) tail is removed in the
presence of Caf1a-AA. This is in line with the notion that
Caf1 takes part in the second, rapid phase of
deadenylation, as pointed out by Yamashita et al. (22).
Figure 3. Not1 is required for mRNA decay induced by tethering of TTP. (A) HeLa cells were transiently transfected with MS2cp, MS2cp-TTP or
the zinc-ﬁnger mutant MS2cp-TTP-M1,2 that does not bind mRNA by itself. In addition, a pTet-Off-driven b-globin reporter gene that contains six
MS2-binding sites (bs) in its 30 UTR together with the Tet-Off transactivator were transfected into all cells. Transcription of the reporter gene was
turned off by treating cells with doxycycline. RNA was isolated after the indicated time intervals. Globin-MS2bs and nucleolin mRNA levels were
detected by northern blot analysis. The bottom graph shows quantiﬁcation of the globin-MS2bs mRNA. Average values±SE from three biological
repeat experiments are represented. (B) HeLa cells were transfected simultaneously with either two control siRNAs or two siRNAs targeting Not1.
After 48h, cells were transfected with the same siRNAs again together with MS2cp-TTP-M1,2, the pTet-Off-globin-MS2bs reporter gene and the
Tet-Off transactivator; 24h later, cells were treated with doxycycline and total RNA was isolated after the indicated time intervals. Globin-MS2bs
and nucleolin mRNA levels were detected by northern blot analysis. For quantiﬁcation, signal intensities of globin-MS2bs mRNA were normalized
to nucleolin mRNA and represented as percentage of the initial value. The bottom graph shows average values±SE from four biological repeat
experiments.
Nucleic Acids Research, 2011,Vol.39, No. 10 4379The effect on deadenylation was visualized by plotting
the mRNA signal intensity along the length of the
mRNA signal (Figure 4B, middle panel). Quantiﬁcation
of the mRNA decay rate from three biological repeat
experiments (Figure 4B, bottom panel) showed that
Caf1a-AA increased the mRNA half-life by >2-fold.
The C-terminal domain of TTP is critical for recruitment
of Not1 and Caf1
TTP contains in its central part a tandem CCCH
zinc-ﬁnger domain that is required for binding of AREs
(13), whereas the N-terminal domain of TTP was found to
stimulate mRNA decay by recruiting components of the
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Figure 4. Caf1 interacts with TTP and mediates deadenylation of globin-ARE-mRNA. (A) HeLa cells were transiently transfected with YFP, YFP–
TTP or TTP–M1,2. Cytoplasmic lysates (input) were prepared after 24h for IP with GFP-binder. Inputs were divided and one half was treated with
RNase A during IP. Western blot analysis was carried out with antibodies against YFP and endogenous Caf1a. (B) HeLa cells were transiently
transfected with TTP, the Tet-Off transactivator and a pTet-Off-driven b-globin reporter gene containing the ARE of TNF-a in its 30-UTR. Cells
were co-transfected with either empty vector, Caf1a-wt or dominant negative Caf1a-AA. Reporter gene transcription was blocked speciﬁcally by
addition of doxycycline 20h after transfection, and total RNA was isolated after the indicated time intervals. Globin-ARE and nucleolin mRNA
were detected by northern blot analysis. dT indicates that the RNA was treated with oligo-dT and RNase H to generate deadenylated mRNA. In the
middle panel, deadenylation was visualized by quantifying the signal intensity of globin-ARE mRNA along the length of the signal and plotting it as
a function of mRNA size. In the bottom panel, the overall signal intensity of globin-ARE mRNA was quantiﬁed and normalized to nucleolin
mRNA. Average values±SE were obtained from three biological repeat experiments and plotted as % of the initial time point.
4380 Nucleic Acids Research, 2011,Vol.39, No. 10general mRNA decay machinery (20). To further under-
stand the interaction of TTP with Not1 and Caf1, we ex-
pressed the N- and C-terminal domains of TTP,
schematically depicted in Figure 5A, in HEK293 cells.
By co-IP analysis we found that the N-terminal domain
of TTP (amino acid 1–94) does not interact with either
Caf1a or Flag-Not1 (Figure 5B, lane 10). The NZ
fragment (amino acid 1–176) comprising the N-terminus,
the zing-ﬁnger domain and a small part of the C-terminal
domain showed only a very weak interaction with
Flag-Not1 or Caf1a (lane 12). In contrast, the
C-terminal domain (amino acid 152–319) was able to
co-IP Flag-Not1 and Caf1a as efﬁciently as full-length
TTP (compare lanes 8 and 14). Treatment of the
samples during IP with RNase I, which also cleaves
RNA within a poly(A) tail, did not abrogate the inter-
action with either Flag-Not1 or Caf1a (lanes 9 and 15).
Efﬁcient degradation of RNA is shown in the bottom
panels of Figure 5B for rRNA and nucleolin as an
abundant mRNA. Since TTP–Not1/Caf1a interactions
are technically challenging to detect, a repeat IP is
shown in Supplementary Figure S1A and B. From these
results we concluded that Not1 and Caf1a primarily
interact with the C-terminal domain of TTP in an RNA-
independent manner. We further tested the interaction of
TTP with Ccr4a and again found the C-terminal domain
of TTP to associate with HA-Ccr4a (Supplementary
Figure S1C).
To functionally compare the N- and C-terminal
domains of TTP, we again made use of the tethering
assay. TTP-N and TTP-C were fused to the MS2cp, and
both fragments were found to induce very rapid
deadenylation and decay of the globin-M2bs mRNA
(Figure 5C). Co-expression of the dominant-negative
Caf1a-AA mutant efﬁciently prevented deadenylation of
the tethered reporter mRNA and reduced its decay rate
(Figure 5C, bottom panels). Taken together, these results
provide strong evidence that the interaction of the TTP
C-terminal domain with Not1–Caf1a is functionally
relevant for the destabilizing activity of TTP. However,
it is interesting to note that the N-terminal domain can
also activate deadenylation and mRNA decay, although
we do not detect an interaction with Not1/Caf1a.
Similarly, a previous study by Lykke-Andersen and
Wagner (2005) had found that both the N- and
C-terminal domains of TTP mediate mRNA degradation
(20).
Interaction of TTP with Not1 is extensive and required
for Caf1 recruitment
To further examine the interactions between TTP, Not1
and Caf1a, we divided the human Not1 cDNA, which
encodes for a 2376-amino acid long protein, into several
fragments (Figure 6A). The most N-terminal fragment of
Not1 encompassing amino acid 1–700 did not co-IP with
TTP, whereas a longer N-terminal fragment covering
amino acid 1–997 did interact with TTP (Figure 6B,
lanes 7 and 8). Importantly, neither of these two fragments
showed an interaction with Caf1a. This result suggests
that the Not1 region between amino acid 700 and 997 is
important for the interaction with TTP, and that TTP can
associate with Not1 independently of Caf1.
Our previous yeast two-hybrid experiments mapping
the interactions between human Ccr4-Not subunits
indicated that Caf1a/CNOT7 interacts with amino acid
648–2376 of Not1 (28). We further examined the middle
region of Not1 using a fragment that spans amino acid
727–1449. This fragment was able to co-IP with both TTP
and Caf1a (Figure 6C, lane 6). Interestingly, a smaller
Not1:1330–1601 fragment shifted slightly toward the
C-terminus interacted efﬁciently with TTP, but not with
Caf1a (lane 7). The last fragment we tested contains the
C-terminus of Not1 (amino acid 1880–2373), and did not
interact with either TTP or Caf1a (lane 8). Taken together,
it is evident that TTP and Caf1a interact with different
though overlapping regions of Not1. TTP shows a more
extensive interaction with Not1 in the region between
amino acid 700 and 1601, whereas the interaction
with Caf1 is restricted to the region between amino acid
727–1499 of human Not1.
Finally, we wanted to test if the interaction between
TTP and Caf1 is dependent on Not1. To this end, we
knocked down Not1 expression in HeLa cells. Co-IP ex-
periments clearly showed that the interaction between
YFP-TTP and endogenous Caf1a is lost after knock
down of Not1, whereas in a control knock down the inter-
action was unaffected (Figure 6D, lanes 6 and 8). Taken
together, these results provide compelling evidence that
Not1 provides a platform on which TTP recruits the
Caf1 deadenylase to its target mRNAs.
DISCUSSION
Initially, the Not proteins were identiﬁed by genetic
studies in S. cerevisiae as general repressors of transcrip-
tion that preferentially act on promoters lacking a canon-
ical TATA box (Negative on TATA, Not). This function
is mediated through regulation of the TFIID transcription
complex and histone modiﬁcation by the Not proteins
(48,52). In parallel, catabolite repressor protein 4 (Ccr4)
was identiﬁed as a factor required for the expression of
genes that are induced under non-fermentative conditions.
Biochemical studies then revealed that Ccr4 and Not
proteins are actually part of the same complex (53). In
addition to its functions in the nucleus, the yeast Ccr4–
Not complex was found to play an important role in the
cytoplasm where Ccr4 and Caf1 represent the two major
exoribonucleases responsible for cytoplasmic mRNA
deadenylation (34,35,37).
In metazoa, the Ccr4–Not complex shares many of
its characteristics with the yeast complex. In the nucleus,
the human complex serves as a negative regulator of
transcription through its subunits Not1, Not2 and
Caf40 (30,31). Moreover, Not1 interacts with the ligand-
binding domain of estrogen receptor alpha and represses
estrogen receptor-mediated transcription (31). The gen-
eral role of the cytoplasmic Ccr4–Not complex in
mRNA deadenylation is also conserved in metazoa
(22,49). In contrast to yeast, however, Caf1 was found
to be the major deadenylase in trypanosomes as well as
Nucleic Acids Research, 2011,Vol.39, No. 10 4381in Drosophila and human cells, whereas Ccr4 is either
lacking (in trypanosomes) or of minor importance for
deadenylation (25,27,49). Aside from Caf1 that carries
the exoribonucleolytic activity, a detailed analysis in
Drosophila cells showed that Not1, Not2 and Not3 are
also essential for deadenylation of both bulk and Hsp70
mRNA (38). The exact role of these proteins in mRNA
deadenylation, however, is not known.
In this study, we provide evidence through biochemical
puriﬁcation and co-IP experiments that TTP associates
with Not1 (Figure 1). TTP binds to mRNAs
containing AREs and mediates their rapid degradation,
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4382 Nucleic Acids Research, 2011,Vol.39, No. 10and indeed we found that Not1 is required for efﬁcient
AMD (Figure 2). Using a tethering assay whereby TTP is
bound to a reporter mRNA through a heterologous inter-
action, we could further show that mRNA decay that is
strictly dependent on TTP also requires Not1 (Figure 3).
Moreover, we found that TTP co-IPs with Caf1a, and
that TTP-induced mRNA deadenylation is inhibited by a
dominant-negative mutant of Caf1a (Figure 4). Thus, both
Caf1 and Not1 are essential for the ability of TTP to
deadenylate and destabilize its target mRNAs. A key
ﬁnding was that TTP interacts with Caf1a only when
Not1 is present (Figure 6D). Taken together, these results
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Nucleic Acids Research, 2011,Vol.39, No. 10 4383provide strong evidence that TTP interacts with Not1 in
order to recruit the Caf1a deadenylase, which in turn
induces rapid deadenylation of the mRNA bound to
TTP. Our view of the functional relationship between
TTP, Not1 and Caf1 is schematically depicted in
Figure 7. In this model, TTP plays a central role in selective
deadenylation of speciﬁc mRNAs. Recent experiments in
mousegermcellsindicatethattheNanos2proteinperforms
an analogous role in recruiting the Ccr4–Not complex to
meiosis-speciﬁc mRNAs for degradation in cytoplasmic
P-bodies (54).
Interaction studies in S. cerevisiae suggested that Ccr4/
Caf1 bind to a middle fragment of yeast Not1 comprising
amino acid 667–1152 (55). This region corresponds to amino
acid 918–1453 in human Not1, which is in good agreement
with our observation that the human Not1:727–1449
fragment interacts with Caf1a (Figure 6C). In contrast to
Caf1a, we found that TTP associates with a larger region
of Not1 that comprises amino acid 700–1601. Importantly,
TTP interacts not only with the Not1:727–1449 frag-
ment that also co-IPs with Caf1a, but in addition with the
two non-overlapping fragments Not1:1–997 and Not1:
1330–1601. From this we concluded that TTP engages in
an extensive interaction with Not1 that involves at least
two separate interaction domains. However, because co-IP
experiments cannot prove that two proteins are in direct
contact, future experiments using recombinant proteins will
have to address whether TTP and Not1 directly bind to each
other.
Our analysis of TTP subfragments showed that the
C-terminal domain of TTP interacts with both Not1 and
Caf1a (Figure 5B). Interestingly, both the N- and
C-terminal domains were able to cause mRNA
deadenylation of a tethered reporter mRNA in a Caf1a-
dependent manner (Figure 5C). Indeed, a previous study
by Lykke-Andersen and Wagner (2005) had shown that
the N-terminal domain of TTP interacts with various
factors of the RNA decay machinery including Ccr4, the
decapping enzyme Dcp2, the 50-30 exonuclease Xrn1 and
Rrp4, a component of the exosome that has 30-50 exonucle-
ase activity. This analysis could not assign any
interactions to the C-terminal domain of TTP although
the C-terminal domain was found to cause mRNA
decay more efﬁciently in a tethering assay than the
N-terminal domain (20). Our ﬁnding that the C-terminal
domain efﬁciently associates with Not1–Caf1 provides an
explanation for the high activity of the C-terminal
domain. It remains unclear why Ccr4a interacts with the
C-terminal domain of TTP in our hands (Supplementary
Figure S1C), whereas it was immunoprecipitated with the
N-terminal domain of TTP in the study of
Lykke-Andersen and Wagner (2005).
TTP is known to be regulated in its activity through
phosphorylation at two speciﬁc serine residues (S52 and
S178) by the MK2 kinase (40,56). Phosphorylation at
these two sites causes binding of 14-3-3 adaptor proteins
and inhibition of TTP, which allows for a transient stabil-
ization of TTP-target mRNAs (40). Very recently, phos-
phorylation of TTP was shown to reduce its interaction
with Ccr4 and Caf1 (25,57). It will now be interesting to de-
termine whether the TTP–Not1 interaction we describe
here is also affected by phosphorylation, or whether the
Not1–Caf1 interaction might be subject to regulation.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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